MediPharm Labs Corp. (TSE:LABS – Get Free Report) shares were up 7.1% during mid-day trading on Monday . The company traded as high as C$0.08 and last traded at C$0.08. Approximately 197,758 shares were traded during trading, a decline of 3% from the average daily volume of 203,964 shares. The stock had previously closed at C$0.07.
MediPharm Labs Stock Performance
The company has a debt-to-equity ratio of 4.33, a current ratio of 3.37 and a quick ratio of 3.10. The firm has a market capitalization of C$28.34 million, a PE ratio of -1.75 and a beta of 0.91. The business’s 50-day moving average price is C$0.07 and its 200-day moving average price is C$0.07.
MediPharm Labs Company Profile
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.
Featured Articles
- Five stocks we like better than MediPharm Labs
- What is the Nikkei 225 index?
- Survey: Top 175 Fittest Retirement Locations in America
- Manufacturing Stocks Investing
- Kimberly-Clark Stock Dips and a Buying Opportunity Emerges
- When to Sell a Stock for Profit or Loss
- Leading Gold Stock Shines With Q2 2024 Earnings Release
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
